Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in β-cells

被引:52
作者
Mariot, P [1 ]
Gilon, P [1 ]
Nenquin, M [1 ]
Henquin, JC [1 ]
机构
[1] Univ Catholique Louvain, Unite Endocrinol & Metab, B-1200 Brussels, Belgium
关键词
D O I
10.2337/diabetes.47.3.365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sulfonylureas stimulate insulin secretion by blocking ATP-sensitive K+ channels (K+-ATP channels) of the beta-cell membrane, thereby causing depolarization, Ca2+ influx, and rise in cytoplasmic Ca concentration ([Ca2+](i)), whereas diazoxide inhibits insulin secretion by opening K+-ATP channels. It has been suggested recently that these drugs also respectively increase and decrease the efficacy of Ca2+ on exocytosis. This hypothesis was tested here with intact islets or single beta-cells from normal mice. Depolarizing islet cells by raising extracellular K+ from 4.8 to 15, 30, and 60 mmol/l progressively raised [Ca2+](i) and stimulated insulin secretion. The magnitude of the [Ca2+](i) rise produced by a subsequent addition of 100 mu mol/l tolbutamide decreased as the concentration of K+ was increased. The effect on insulin secretion paralleled that on [Ca2+](i). Similarly, the magnitudes of the [Ca2+](i) drop and of the inhibition of insulin secretion produced by 250 mu mol/l diazoxide were inversely related to the concentration of K+. Either drug was effective on secretion only when it increased or decreased [Ca2+](i). Exocytosis of insulin granules from single, voltage-clamped beta-cells was also studied by measuring cell capacitance changes. In the perforated patch configuration, exocytosis was evoked by depolarizing pulses. Addition of tolbutamide to the extracellular medium did not affect the Ca2+ current and the resulting change in cell capacitance. In the whole-cell configuration, cell capacitance increased with the concentration of free Ca2+ in the solution diffusing from the pipette into the cell. It was markedly potentiated by cAMP, was inhibited by activation of alpha(2)-adrenoceptors with clonidine, and was strongly augmented by acetylcholine. In contrast, tolbutamide was ineffective whether applied intra- or extracellularly, at low or high free Ca2+, and with or without cAMP. Diazoxide also failed to interfere directly with exocytosis. These results indicate that tolbutamide and diazoxide affect insulin secretion by changing the concentration, not the action, of Ca2+ in beta-cells.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 43 条
  • [1] CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION
    AGUILARBRYAN, L
    NICHOLS, CG
    WECHSLER, SW
    CLEMENT, JP
    BOYD, AE
    GONZALEZ, G
    HERRERASOSA, H
    NGUY, K
    BRYAN, J
    NELSON, DA
    [J]. SCIENCE, 1995, 268 (5209) : 423 - 426
  • [2] CALCIUM-INDEPENDENT POTENTIATION OF INSULIN RELEASE BY CYCLIC-AMP IN SINGLE BETA-CELLS
    AMMALA, C
    ASHCROFT, FM
    RORSMAN, P
    [J]. NATURE, 1993, 363 (6427) : 356 - 358
  • [3] STIMULUS-SECRETION COUPLING IN PANCREATIC BETA-CELLS
    ASHCROFT, FM
    PROKS, P
    SMITH, PA
    AMMALA, C
    BOKVIST, K
    RORSMAN, P
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 55 : 54 - 65
  • [4] THE SULFONYLUREA RECEPTOR
    ASHCROFT, SJH
    ASHCROFT, FM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1175 (01) : 45 - 49
  • [5] COUPLING OF EXOCYTOSIS TO DEPOLARIZATION IN RAT PANCREATIC-ISLET BETA-CELLS - EFFECTS OF CA2+, SR2+ AND BA2+-CONTAINING EXTRACELLULAR SOLUTIONS
    BARNETT, DW
    MISLER, S
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1995, 430 (04): : 593 - 595
  • [6] COOK DL, 1997, ELLENBERG RIFKINS DI, P49
  • [7] Glucose-induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal beta-cells (HIT)
    Cunningham, BA
    Deeney, JT
    Bliss, CR
    Corkey, BE
    Tornheim, K
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 271 (04): : E702 - E710
  • [8] PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells
    Eliasson, L
    Renstrom, E
    Ammala, C
    Berggren, PO
    Bertorello, AM
    Bokvist, K
    Chibalin, A
    Deeney, JT
    Flatt, PR
    Gabel, J
    Gromada, J
    Larsson, O
    Lindstrom, P
    Rhodes, CJ
    Rorsman, P
    [J]. SCIENCE, 1996, 271 (5250) : 813 - 815
  • [9] FLATT PR, 1994, DIABETES METAB, V20, P157
  • [10] FUHLENDORFF J, 1995, PHARM RES S1, V31, P32